RESUMEN
OBJECTIVES: To compare the impact of clomiphene citrate (CC) vs other drug regimens on mid-cycle endometrial thickness (EMT), ovulation, pregnancy and live birth rates in women with World Health Organization (WHO) group II ovulatory disorders. METHODS: We searched MEDLINE, EMBASE, Scopus, Web of Science, The Cochrane Central Register of Clinical Trials (CENTRAL) and the non-MEDLINE subset of PubMed from inception to December 2016 and cross-checked references of relevant articles. We included only randomized controlled trials (RCTs) comparing CC used alone vs other drug regimens for ovulation induction in women with WHO group II anovulation. Outcomes were mid-cycle EMT, ovulation, pregnancy and live birth rates. We pooled weighted mean differences (WMD) with 95% confidence intervals (CI) for continuous variables (EMT) and risk ratios (RR) with 95% CI for binary variables (ovulation, pregnancy and live birth rates). RESULTS: We retrieved 1718 articles of which 33 RCTs (4349 women, 7210 ovulation induction cycles) were included. In 15 RCTs that compared CC with letrozole, EMT was lower in the CC group (1957 women, 3892 cycles; WMD, -1.39; 95% CI, -2.27 to -0.51; I2 = 100%), ovulation rates after CC and letrozole were comparable (1710 women, 3217 cycles; RR, 0.97; 95% CI, 0.90-1.04; I2 = 47%), while CC led to a lower pregnancy rate (1957 women, 3892 cycles; RR, 0.78; 95% CI, 0.63-0.95; I2 = 43%) and a lower live birth rate (RR, 0.70; 95% CI, 0.49-0.98; I2 = 35%). In two RCTs that compared CC with CC plus metformin, EMT, ovulation and pregnancy rates were comparable (101 women, 140 cycles; WMD, -0.23; 95% CI, -0.92 to 0.45; I2 = 78%; RR, 0.84; 95% CI, 0.67-1.06; I2 = 0%; and RR, 0.79; 95% CI, 0.33-1.87; I2 = 0%). In three studies that compared CC with CC plus N-acetyl cysteine (NAC), EMT was lower in the CC group (340 women, 300 cycles; WMD, -1.51; 95% CI, -1.98 to -1.04; I2 = 45%). In two studies that compared CC with CC + nitric oxide (NO) donor, EMT was lower in the CC group (120 women, 304 cycles; WMD, -1.75; 95% CI, -2.08 to -1.41; I2 = 0%). Compared with CC plus NO donor or NAC, CC showed statistically significant lower ovulation and pregnancy rates. Compared with tamoxifen in three studies, CC showed a tendency towards lower EMT (571 women, 844 cycles; WMD, -1.34; 95% CI, -2.70 to 0.01; I2 = 96%) with comparable ovulation and pregnancy rates. CONCLUSIONS: In women with WHO group II ovulatory disorders, ovulation induction with CC might result in lower EMT than other ovulation induction regimens. Whether the lower EMT caused the lower pregnancy and live birth rates remains to be elucidated. Letrozole seems to be beneficial for these women. However, our findings should be interpreted with caution as the quality of evidence was very low. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
Asunto(s)
Anovulación/tratamiento farmacológico , Tasa de Natalidad , Clomifeno/uso terapéutico , Endometrio/efectos de los fármacos , Antagonistas de Estrógenos/uso terapéutico , Nacimiento Vivo , Tamoxifeno/uso terapéutico , Endometrio/patología , Femenino , Fármacos para la Fertilidad Femenina , Humanos , Recién Nacido , Inducción de la Ovulación , Embarazo , Resultado del Embarazo , Índice de Embarazo , Ensayos Clínicos Controlados Aleatorios como AsuntoRESUMEN
The present study was carried out to determine the prevalence, age of first starting smoking and the risk factors associated with taking up regular smoking. The study included 1291 University students (861 males and 430 females), their ages ranged from 17 to 28 years. The over all percentage of smokers was 37.9% (52% males and 9% females), and 21% of males and 12% of females started smoking before the age of 14 and 80% of males and 57% of females before reaching 18 years of age. Smoker peer colleagues, high income, owning of a car, and family troubles, using drugs, smoking hashish and drinking alcohol are significant associated risk factors to taking up smoking.
Asunto(s)
Fumar/epidemiología , Estudiantes/estadística & datos numéricos , Adolescente , Adulto , Factores de Edad , Egipto/epidemiología , Femenino , Humanos , Masculino , Proyectos Piloto , Prevalencia , Factores de Riesgo , Factores Sexuales , UniversidadesRESUMEN
Effects of crystallization of poorly water soluble sulfamethoxazole in aqueous surfactants solutions on its in vitro dissolution rates were investigated. Marked enhancement was observed. Infrared spectra studies on the prepared crystals indicated polymorphic changes. Some factors affecting the dissolution rate enhancement of crystals prepared in the presence of surfactant namely, the type of the dissolution apparatus, the method of preparation, the type of surfactant, the concentration of surfactant, and washing and soaking of the crystals, were studied. The results of the different effects and possible mechanisms involved are discussed.
Asunto(s)
Sulfametoxazol/análisis , Química Farmacéutica , Cristalización , Cinética , Solubilidad , TensoactivosRESUMEN
Doses of procaine for dental purposes have been assessed previously as a result of studies of circulating blood levels of procaine after injection of the drug at body sites other than the mouth. This paper reports results of a study of circulating procaine levels in ten healthy volunteers who received 1.8 ml injections of 2% procaine hydrochloride at a defined peri-oral site. General dental practice conditions were simulated as closely as possible. In addition, procaine pharmacokinetics following peri-oral administration were studied. The serum concentration-time data were found to obey the one-compartment open model adequately with first-order absorption and elimination rates.
Asunto(s)
Procaína/sangre , Adulto , Disponibilidad Biológica , Semivida , Humanos , Inyecciones , Cinética , Masculino , Boca , Procaína/administración & dosificación , Procaína/metabolismoRESUMEN
The stability of chlorpromazine hydrochloride in some hypothetical tablet formulations was evaluated through a fractional factorial design of the type N = 2(6-3). The factors studied were the type of filler (X1), lubricant (X2), binder (X3), disintegrant (X4), the absence or presence of light ( X5 ) and/or humidity ( X6 ). Statistical analysis of the stability data allowed the derivation of a regression equation which determined the magnitude and direction of change of each factor level to optimize drug stability. The significance of the factors could be arranged in the following order: X5 greater than X2 greater than X3 greater than X6 greater than X1. The effects of X4 and the two-factor interaction X2X3 were found to be insignificant. The best multi-component excipient mixture was evaluated on the basis of the information deduced from the factorial design.
Asunto(s)
Química Farmacéutica/métodos , Clorpromazina/análisis , Análisis de Varianza , Estabilidad de Medicamentos , Almacenaje de Medicamentos , Excipientes/farmacología , Humedad , Luz , Análisis de Regresión , ComprimidosRESUMEN
The effect of different concentrations of some selected salts, namely, sodium chloride, potassium chloride, ammonium chloride, monosodium dihydrogen phosphate, calcium chloride, dibasic sodium phosphate, sodium sulphate, aluminium chloride and sodium citrate on the antimicrobial activity of nalidixic acid was investigated. It was found that all the salts tested, except aluminium chloride and sodium citrate, exert no antimicrobial activity. The effect of 10% non-ionic surface active agents, namely, Myrj 51, 52, 59, Brij 35, 58, 98, Tween 20, 40, 60, and 80 on the antimicrobial activity of nalidixic acid was studied. The results indicated that the activity of nalidixic acid was decreased in the presence of these surfactants. Furthermore, the effect of different concentrations of sodium chloride on the antimicrobial activity of nalidixic acid-surfactants systems was reported.
Asunto(s)
Bacterias/efectos de los fármacos , Ácido Nalidíxico/farmacología , Cloruro de Sodio/farmacología , Tensoactivos/farmacología , ExcipientesRESUMEN
Five commercial brands of furosemide tablets were evaluated using the official and non-official tests of U.S.P. XIX. These tests include: uniformity of weight, hardness, friability and disintegration time. The results obtained showed that most of these brands failed to attain the U.S.P. requirements. The inclusion of different surface active agents in some of the new suggested formulae was proposed for improving the poor properties of such commercial furosemide tablets. In addition to the above quality control tests, dissolution rate studies of the new formulated tablets were carried out. The addition of 11.4% dioctyl sodium sulphosuccinate increased the dissolution rate up to 48.5% after 60 min. On the other hand, the same concentration of sodium lauryl sulphate caused complete tablet dissolution within 45 min. The effect of a higher concentration of sodium lauryl sulphate on the dissolution rate of furosemide has also been examined.
Asunto(s)
Furosemida/análisis , Dureza , Micelas , Solubilidad , Comprimidos/análisis , Factores de TiempoRESUMEN
Five commercial brands of furosemide tablets from different manufacturers, namely, S, F, Ls, L and Fr were elected for this study. The dissolution rate studies of these brands demonstrated vast differences in drug release characteristics. Only two batches of Fr and one batch of F brands fulfilled the U.S.P. dissolution test, while the other failed to meet the requirements of this test. The dissolution rate studies of different batches the same commercial brand showed a larger interlot variation within certain brands. These interlot variations were by far smaller than the dissolution rate differences between the different brands. Studies on the drug content for each furosemide brand showed a great variation between the brands and also within the different batches of the same brand.
Asunto(s)
Furosemida , Química Farmacéutica , Furosemida/análisis , Cinética , Solubilidad , Comprimidos , Factores de TiempoRESUMEN
A high-pressure liquid chromatographic method was developed for chloramphenicol in plasma. Plasma samples were deproteinized with 2.5 volumes of acetonitrile, and the supernates were chromatographed on a reversed-phase column, using acidified ethanol-water as the mobile phase and UV spectrophotometry for detection. The sensitivity for accurate quantitation of chloramphenicol was about 2.5 microgram/ml in plasma, and concentrations as low as 0.5 microgram/ml could be detected. Only about 8 min is needed for each sample. This method is specific, rapid, and sufficiently sensitive and may be useful for clinical monitoring.
Asunto(s)
Cloranfenicol/sangre , Animales , Cromatografía Líquida de Alta Presión , Humanos , Métodos , ConejosRESUMEN
A rapid and simple high-pressure liquid chromatographic method was developed for the simultaneous determination of plasma levels of procainamide and its major metabolite, N-acetonitrile, and the supernate was chromatographed on a cation-exchange column. The assay can be carried out on as little as 20 microliter of plasma and requires only about 7 min for each sample. No interference was found in plasma samples from cardiac patients receiving procainamide. This method is simple, fast, and useful for routine therapeutic monitoring and for pharmacokinetic studies procainamide and its metabolite.
Asunto(s)
Procainamida/sangre , Acetilación , Cromatografía Líquida de Alta Presión , Humanos , Métodos , Microquímica , Espectrofotometría UltravioletaRESUMEN
A rapid and sensitive high-pressure liquid chromatographic assay was developed for aspirin, salicylic acid, and salicyluric acid in plasma. The procedure involves the solvent extraction of these compounds from plasma and separation using a reversed-phase column eluted by acidified aqueous acetonitrile. Small quantitites of aspirin can be assayed directly in the presence of a large quantity of salicylic acid. The assay is also free from blank interference.
Asunto(s)
Aspirina/sangre , Hipuratos/sangre , Salicilatos/sangre , Cromatografía Líquida de Alta Presión , Métodos , Factores de TiempoAsunto(s)
Esquema de Medicación , Tasa de Depuración Metabólica , Preparaciones Farmacéuticas/metabolismo , Animales , Humanos , Infusiones Parenterales , Modelos Biológicos , Preparaciones Farmacéuticas/administración & dosificación , Preparaciones Farmacéuticas/sangre , Conejos , Teofilina/administración & dosificación , Teofilina/sangreRESUMEN
A high-performance liquid-chromatographic method is reported for monitoring theophylline in plasma. Samples are deproteinized with 2.5 volumes of acetonitrile and the supernates chromatographed on a reversed-phase column. Absorption at 275 nm is monitored. One can accurately measure 1.5 mg of theophylline per liter, in as little as 10 microliter of plasma, and only about 7 min is required per sample. No interference was found in plasma samples from asthmatic patients. This method is particularly useful for routine therapeutic monitoring of both pediatric and adult patients.
Asunto(s)
Teofilina/sangre , Cromatografía Líquida de Alta Presión/métodos , HumanosRESUMEN
Previously published methods for endogenous creatinine levels in plasma, serum, or urine lack specificity or are subject to interferences from endogenous or exogenous substances. The developed simple, rapid, and specific high-pressure liquid chromatographic method includes the novel deproteinization and extraction of 1 volume of plasma or serum with 2.5 volumes of acetonitrile and also of 1 volume of urine with 40 volumes of a 20% water-80% acetonitrile solution. An aliquot of the supernate is then injected directly into the chromatograph. A cation-exchange column and acidified (0.02% of 85% phosphoric acid) 0.1 M ammonium phosphate solution as the mobile phase, with a flow rate of 2 ml/min, were used. Creatinine, with a retention time of 3.8 min, was monitored via its UV absorption at 215 nm. Both peak heigh and integrated area methods of quantitation yielded the same results. Several methods were employed to show that the "suspected" creatinine peak from plasma samples was due entirely to the "true" creatinine. No interference was found in samples obtained from normal and renal patients. The day-to-day variation in the detector response was small. Each assay requires only about 5 min for completion. Ten microliters of plasma or serum or 1 microliter of urine is sufficient for analysis.
Asunto(s)
Creatinina/análisis , Adulto , Cromatografía Líquida de Alta Presión/métodos , Creatinina/sangre , Creatinina/orina , Estudios de Evaluación como Asunto , Humanos , Microquímica/métodos , Espectrofotometría UltravioletaRESUMEN
A rapid, specific method for measuring gentamicin in plasma by high-pressure liquid chromatography was developed. After deproteinization, gentamicin in the supernate was dansylated and extracted into ethyl acetate. The organic extract was chromatographed on a microparticulate reversed-phase column, which was eluted with aqueous acetonitrile. Use of the dansyl derivative enables fluorometry, for more sensitive quantitation. Various factors that could affect the assay sensitivity were investigated. With 0.2-ml plasma samples, the method can accurately measure as little as 1 mg of gentamicin per liter. We encountered no interferences from plasma supplemented with various drugs or plasma of patients who were on therapy with other drugs. This method can also separate gentamicin C1 from C1a and C2, all of which are present in various ratios in commercial dosage forms. This method is also applicable to gentamicin determination in urine.
Asunto(s)
Gentamicinas/sangre , Animales , Cromatografía Líquida de Alta Presión , Compuestos de Dansilo/farmacología , Humanos , Métodos , Conejos , Hidróxido de Sodio/farmacología , Temperatura , Factores de TiempoRESUMEN
A high pressure liquid chromatographic method for the separation and quantitative determination of sulfisoxazole in plasma was developed. Plasma samples were vortex-mixed with acetonitrile and centrifuged to obtain clear supernatant solutions. The supernate was chromatographed on a reverse phase column using acidified aqueous ethanol as mobile phase to effect separation. The separated components were detected by UV absorption at 280 nm and the peak height measurement was used for quantitative determination. This assay is simple and rapid. Each assay takes less than 8 minutes to complete and can be carried out on as little as 10 microliter plasma samples to accurately measure 2.0 microgram/ml of sulfisoxazole in plasma. This method can be used for an efficient monitoring of sulfisoxazole in plasma during the chemotherapy of bacterial infections, and also for the bioavailability study of the drug from dosage forms.